Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial (2008)

Author(s): Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swaab EA, Laughlin MA, on behalf of the Tarenflurbil Phase II Study Investigators

      • Date: 29-04-2008
      • Journal: Lancet Neurology
      • Volume: 7
      • Issue: 6
      • Pages: 483-493
      • Publisher: The Lancet Publishing Group
      • Publication type: Article
      • Bibliographic status: Published

      Professor Ian McKeith
      Professor of Old Age Psychiatry